BCL2/BAX modulator-1
BCL2/BAX modulator-1 is an orally active BCL2/BAX modulator and apoptosis inducer. BCL2/BAX modulator-1 downregulates BCL2 mRNA expression, upregulates BAX mRNA expression, and occupies the BAX trigger site. BCL2/BAX modulator-1 can be used for research on prostate adenocarcinoma, hepatocellular carcinoma, and lung adenocarcinoma.
For research use only. We do not sell to patients.
- CAS No.: 1416344-06-3
- Formula: C18H18N2O2
- Molecular Weight:294.35
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| LNCaP | IC50 |
11.84 μM
|
Cytotoxic activity against human prostate adenocarcinoma LNCaP cells assessed as reduction in cell viability incubated for 48 hrs by WST-1 colorimetric assay.
Cytotoxic activity against human prostate adenocarcinoma LNCaP cells assessed as reduction in cell viability incubated for 48 hrs by WST-1 colorimetric assay.
|
42556024 |
| HepG2 | IC50 |
19.59 μM
|
Cytotoxic activity against human hepatocellular carcinoma HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by WST-1 colorimetric assay.
Cytotoxic activity against human hepatocellular carcinoma HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by WST-1 colorimetric assay.
|
42556024 |
| A549 | IC50 |
20.22 μM
|
Cytotoxic activity against human lung adenocarcinoma A549 cells assessed as reduction in cell viability incubated for 48 hrs by WST-1 colorimetric assay.
Cytotoxic activity against human lung adenocarcinoma A549 cells assessed as reduction in cell viability incubated for 48 hrs by WST-1 colorimetric assay.
|
42556024 |
| HEK-293T | IC50 |
65.28 μM
|
Cytotoxic activity against non-cancerous human embryonic kidney 293T cells assessed as reduction in cell viability incubated for 48 hrs by WST-1 colorimetric assay.
Cytotoxic activity against non-cancerous human embryonic kidney 293T cells assessed as reduction in cell viability incubated for 48 hrs by WST-1 colorimetric assay.
|
42556024 |
In Vitro
BCL2/BAX modulator-1 (2h) (0-100 μM; 48 h) exhibits potent cytotoxic activity against LNCaP, HepG2, and A549 cancer cell lines, with the highest potency observed in LNCaP cells (IC50=11.84 μM), while showing lower cytotoxicity toward non-cancerous 293T cells[1].
BCL2/BAX modulator-1 demonstrates a pro-apoptotic effect in A549 cells by significantly up-regulating BAX mRNA expression and down-regulating BCL2 mRNA expression[1].
BCL2/BAX modulator-1 is predicted to bind to the BAX trigger site, forming a hydrogen bond with Gln32, which may contribute to its pro-apoptotic activity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:LNCaP, HepG2, A549, 293T
-
Concentration:0, 5, 12.5, 37.5, 45, 65, 87.5, 100 μM
-
Incubation Time:48 h
-
Result:Showed pronounced cytotoxic activity against LNCaP cells with an IC50 of 11.84 μM.
Exhibited an IC50 of 19.59 μM against HepG2 cells.
Exhibited an IC50 of 20.22 μM against A549 cells.
Exhibited an IC50 of 65.28 μM against non-cancerous 293T cells.
-
Cell Line:A549
-
Concentration:IC50 concentration
-
Incubation Time:24 h
-
Result:Up-regulated pro-apoptotic BAX mRNA expression to a fold change of 1.875.
Down-regulated anti-apoptotic BCL2 mRNA expression to a fold change of 0.401.
Chemical Information
-
CAS No. 1416344-06-3
-
Molecular Weight 294.35
-
Formula C18H18N2O2
-
SMILES
CC(C)C(C=C1)=CC=C1C2=NC3=CC(C(OC)=O)=CC=C3N2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RT-PCR
Reverse transcription technology uses RNA as a template to synthesize DNA. RT-PCR is simple, specific and sensitive, and can be used to detect gene expression levels and expression differences in cells; detect RNA virus content; clone cDNA sequences of specific genes.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
-
Real Time qPCR (Q-PCR)
Real-time quantitative PCR (qPCR) quantifies an amplifiable nucleic-acid target by monitoring fluorescence during PCR cycling rather than measuring product only after amplification. The increase in fluorescence tracks accumulation of PCR product, and the quantification cycle (Cq; historically also Ct/CP) is related to the initial amount of target: samples containing more starting target generally reach the defined fluorescence threshold in fewer cycles.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)